Moxifloxacin Tablet, Film Coated
Product Images NDC 72789-233

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moxifloxacin (NDC 72789-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (72789233)

Label for Moxifloxacin USP 400 mg film-coated tablets, containing 10 tablets per package. Manufactured by PD-Rx Pharmaceuticals, Inc. The label includes dosage strength, quantity, and warnings to keep out of reach of children. It features reorder, lot, and expiration information, with an emphasis on prescription use only.*

FDA Label Image

Figure (Figure)

A line graph showing plasma concentration (µg/mL) over time (hours) comparing oral and intravenous (i.v.) doses of moxifloxacin. The graph plots two lines illustrating similar concentration profiles for both administration routes over 24 hours.*

FDA Label Image

Structure (Structure)

Chemical structure of Moxifloxacin hydrochloride, illustrating its molecular framework including a fluorine atom, cyclic groups, and functional groups characteristic of the active ingredient in Moxifloxacin tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.